Aadi Bioscience Inc

NASDAQ:AADI   3:59:54 PM EDT
22.02
-0.48 (-2.13%)
Products

Aadi Bioscience Announces FDA Approval Of First Product Fyarro

Published: 11/23/2021 14:40 GMT
Aadi Bioscience Inc (AADI) - Aadi Bioscience Announces FDA Approval of Its First Product FYarro™ for Patients With Locally Advanced Unresectable Or Metastatic Malignant Perivascular Epithelioid Cell Tumor (pecoma).
Aadi Bioscience Inc - FYarro Launch Planned for Q1 2022.